GGrantIndex
Sort

23,748 grants matching melanoma

Wounding therapy and photocarcinogenesis

$308,969
Jeffrey B. Travers · Wright State University · R01 · FY2018 · AG

Project 2: Treating metastatic lung cancer by targeting mutated KRAS with engineered T cells

$308,964
Philip D Greenberg · Fred Hutchinson Cancer Center · P50 · FY2025 · CA

Chemical Inhibitors of CREB-mediated Gene Transcription

$308,961
Xiangshu Xiao · Oregon Health & Science University · R01 · FY2013 · GM

Engineered tumor-specific T cells Resist Hypoxic-Tumor Immunosuppressive Attacks.

$308,958
Patricia Yotnda · Baylor College Of Medicine · R01 · FY2011 · CA

Engineered tumor-specific T cells Resist Hypoxic-Tumor Immunosuppressive Attacks.

$308,958
Patricia Yotnda · Baylor College Of Medicine · R01 · FY2012 · CA

Rational targeting of protein translation of cancer treatments

$308,957
France Carrier · University Of Maryland Baltimore · R01 · FY2014 · CA

Developmental Core

$308,955
Jose A Torres-Ruiz · Ponce School Of Medicine · U56 · FY2009 · CA

CORE--MICROARRAY & ANALYSIS SHARED SERVICE

$308,935
Michael John Becich · University Of Pittsburgh At Pittsburgh · P30 · FY2007 · CA

Wounding therapy and photocarcinogenesis

$308,933
Jeffrey B. Travers · Wright State University · R01 · FY2017 · AG

Wounding therapy and photocarcinogenesis

$308,919
Jeffrey B. Travers · Wright State University · R01 · FY2016 · AG

Immunological Monitoring & Cellular Products

$308,898
Theresa L. Whiteside · University Of Pittsburgh At Pittsburgh · P50 · FY2008 · CA

Crucial Microenvironmental Cofactors for Pancreatic Cancer Pathogenesis

$308,894
Eric Collisson · University Of California, San Francisco · R01 · FY2014 · CA

Specific Recognition of G-quadruplexes

$308,882
Hanbin Mao · Kent State University · R01 · FY2022 · CA

"Smart" Nanoparticles for Cancer Therapy and Imaging

$308,821
Joseph M Desimone · Univ Of North Carolina Chapel Hill · U54 · FY2008 · CA

Subpopulations of Human Dendritic Cells

$308,813
Baylor Research Institute · R01 · FY2005 · CA

Generation of Anti-Melanoma T Cells Derived from Human Embryonic Stem Cells

$308,799
Jerome A. Zack · California Institute Of Technology · P01 · FY2011 · CA

Biospecimen and Pathology Core

$308,750
Xiaowei Xu · Wistar Institute · P50 · FY2025 · CA

Impact of IKKB and AurK Inhibitors on Host Immunity and Melanoma

$308,657
Ann Richmond · Vanderbilt University · R01 · FY2013 · CA

A role for c-Abl/Arg in melanoma progression

$308,604
Rina Plattner · University Of Kentucky · R01 · FY2015 · CA

A role for c-Abl/Arg in melanoma progression

$308,604
Rina Plattner · University Of Kentucky · R01 · FY2016 · CA

Clinical Development of Hu14.18-IL2 Targeted Therapy

$308,597
Paul M Sondel · University Of Wisconsin-Madison · R01 · FY2007 · CA

Clinical Development of Hu14.18-IL2 Targeted Therapy

$308,597
Paul M Sondel · University Of Wisconsin-Madison · R01 · FY2008 · CA

Clinical Development of Hu14.18-IL2 Targeted Therapy

$308,597
Paul M Sondel · University Of Wisconsin-Madison · R01 · FY2009 · CA

Core B: Antibody/Ig fusion protein core

$308,587
Gordon James Freeman · Harvard Medical School · P01 · FY2020 · AI

Development of sensory axon pathways in zebrafish

$308,576
Mary C Halloran · University Of Wisconsin-Madison · R01 · FY2010 · NS